Samantha Jaglowski

Samantha Jaglowski

UNVERIFIED PROFILE

Are you Samantha Jaglowski?   Register this Author

Register author
Samantha Jaglowski

Samantha Jaglowski

Publications by authors named "Samantha Jaglowski"

Are you Samantha Jaglowski?   Register this Author

58Publications

2032Reads

41Profile Views

Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.

Biol Blood Marrow Transplant 2019 Oct 20;25(10):1993-2001. Epub 2019 Jun 20.

Division of Hematology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.014DOI Listing
October 2019

Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.

Biol Blood Marrow Transplant 2019 Oct 28;25(10):2002-2007. Epub 2019 Jun 28.

Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.023DOI Listing
October 2019

Tocilizumab as first-line therapy for steroid-refractory acute graft-versus-host-disease: analysis of a single-center experience.

Leuk Lymphoma 2019 Sep 15;60(9):2223-2229. Epub 2019 Feb 15.

Department of Pharmacy, The James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , 43210 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1573996DOI Listing
September 2019

Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II Trial.

Biol Blood Marrow Transplant 2019 Sep 6. Epub 2019 Sep 6.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.09.002DOI Listing
September 2019

Have We Achieved a Goldilocks Grade of Graft-Versus-Host Disease?

Biol Blood Marrow Transplant 2019 Jun 17;25(6):e189-e190. Epub 2019 Apr 17.

Division of Hematology, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.04.009DOI Listing
June 2019

Running the tank to empty: how far can the CAR go?

Blood 2019 Apr;133(15):1617-1618

The Ohio State University.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2019-02
Publisher Site
http://dx.doi.org/10.1182/blood-2019-02-900761DOI Listing
April 2019

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

N Engl J Med 2019 01 1;380(1):45-56. Epub 2018 Dec 1.

From the Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.J.S.); the Hematopoietic Cellular Therapy Program, University of Chicago Medicine, Chicago (M.R.B.); Peter MacCallum Cancer Centre, St. Vincent's Hospital and University of Melbourne, Melbourne, VIC (C.S.T.), and the Royal Prince Alfred Hospital and Department of Medicine, University of Sydney, Sydney (P.J.H.) - both in Australia; Winship Cancer Institute of Emory University, Bone Marrow and Stem Cell Transplant Center, Atlanta (E.K.W.); the Department of Hematology and Oncology, University Hospital of Cologne, Cologne (P.B.), and the Würzburg University Medical Center, Center for Allogeneic Stem Cell Transplantation, Würzburg (S.M.) - both in Germany; the Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City (J.P.M.); the Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna (U.J.); James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus (S.J.); the Department of Hematology and Blood and Marrow Transplant, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (C.A.); the Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (J.R.W.); Maisonneuve-Rosemont Hospital, University of Montreal, Montreal (I.F.), and the Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON (S.R.F.) - both in Canada; the Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis (V.B.); Karolinska Institutet and University Hospital, Department of Laboratory Medicine/Department of Cell Therapy and Allogeneic Stem Cell Transplantation, Stockholm (S.M.); University of Michigan Comprehensive Cancer Center, Ann Arbor (J.M.M.); the Department of Oncology, Oslo University Hospital, Oslo (H.H.); Novartis Pharma, Basel, Switzerland (S.P., O.A.); Novartis Pharmaceuticals (L.B.P., J.C.) and Novartis Institutes for BioMedical Research (R.A.), East Hanover, NJ; the Department of Hematology, Hospices Civils de Lyon, Université de Lyon, Lyon, France (G.S.); and the Center for Hematologic Malignancies, Oregon Health and Science University Knight Cancer Institute, Portland (R.T.M.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804980
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804980DOI Listing
January 2019

How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD.

Blood Adv 2018 08;2(15):2012-2019

Division of Blood and Marrow Transplantation, Department of Pediatrics, The University of Minnesota, Minneapolis, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2018013060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093735PMC
August 2018

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.

Biol Blood Marrow Transplant 2018 01 13;24(1):78-85. Epub 2017 Oct 13.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743624PMC
January 2018

Road trip to remission with CARs.

Blood 2017 11;130(21):2240

THE OHIO STATE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-10-808584DOI Listing
November 2017

A phase 2 trial of alisertib in patients with relapsed or refractory B-cellnon-Hodgkin lymphoma.

Leuk Lymphoma 2017 09 20;58(9):1-2. Epub 2017 Feb 20.

b Division of Hematology , The Ohio State University James Comprehensive Cancer Center , Columbus , OH , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1289527DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497734PMC
September 2017

The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia.

Cancer Med 2017 Apr 15;6(4):778-787. Epub 2017 Mar 15.

Division of Hematology, Department of Internal Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387133PMC
April 2017

Tocilizumab for steroid refractory acute graft-versus-host disease.

Leuk Lymphoma 2016 3;57(1):81-5. Epub 2015 Jul 3.

b Division of Hematology, Department of Internal Medicine , James Cancer Hospital, The Ohio State University Comprehensive Cancer Center , Columbus , Ohio , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1045896DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698359PMC
October 2016

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

J Clin Oncol 2016 09 6;34(26):3141-9. Epub 2016 Jun 6.

Nilanjan Ghosh, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC; Reem Karmali, Rush University Medical Center; Sonali M. Smith, The University of Chicago, Chicago, IL; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Kwang Woo Ahn, Alyssa DiGilio, and Mehdi Hamadani, Medical College of Wisconsin & Center for International Blood and Marrow Transplant Research; Parameswaran N. Hari and Anita D'Souza, Medical College of Wisconsin; Timothy S. Fenske, Froedtert Memorial Lutheran Hospital, Milwaukee, WI; Veronika Bachanova, University of Minnesota Medical Center, Minneapolis, MN; Ulrike Bacher, University Medicine Goettingen and University Cancer Center Hamburg, Hamburg, Germany; Parastoo Dahi, Memorial Sloan Kettering Cancer Center-Adults, New York, NY; Marcos de Lima, University Hospitals Case Medical Center, Cleveland; Samantha Jaglowski, The Ohio State University Medical Center, Columbus, OH; Siddhartha Ganguly, University of Kansas Medical Center, Kansas City, KS; Mohamed A. Kharfan-Dabaja, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Tim D. Prestidge, Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; Bipin N. Savani, Vanderbilt University Medical Center, Nashville, TN; Anna M. Sureda, European Group for Blood and Marrow Transplantation and Hospital Duran I Reynals, Barcelona, Spain; Edmund K. Waller, Winship Cancer Institute, Emory University, Atlanta, GA; Alex F. Herrera, City of Hope National Medical Center, Duarte, CA; Philippe Armand, Dana-Farber Cancer Institute, Boston, MA; Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA; and Nina D. Wagner-Johnston, Ephraim Fuchs, and Javier Bolaños-Meade, Johns Hopkins University Sidney Kimmel Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012706PMC
September 2016

Ibrutinib for treatment of chronic lymphocytic leukemia.

Am J Health Syst Pharm 2016 Mar;73(6):367-75

Division of Hematology, Ohio State University Comprehensive Cancer Center, Arthur G. James Cancer Hospital and Solove Research Institute, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2146/ajhp140760DOI Listing
March 2016

Transplant for CLL: still an option?

Blood 2014 Dec;124(26):3835-6

THE OHIO STATE UNIVERSITY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-10-606871DOI Listing
December 2014

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Sep 9;20(9):1341-8. Epub 2014 May 9.

Division of Bone Marrow Transplantation, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127362PMC
September 2014

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.

N Engl J Med 2014 Jun 28;370(24):2286-94. Epub 2014 May 28.

From the Division of Hematology, Department of Internal Medicine (J.A.W., T.-M.L., A.S.R., S.M.J., K.A.B., A.L., A.J.J., J.C. Byrd), the Department of Biomedical Informatics (H.G.O., A.S.Y.), and the Department of Pathology (G.L.), Ohio State University, Columbus; the Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York (R.R.F.); the Division of Molecular Genetics, German Cancer Research Center, Heidelberg (M.Z., P.L.), and the Department of Internal Medicine III, University of Ulm, Ulm (S.S.) - both in Germany; Pharmacyclics, Sunnyvale, CA (L.X., D.H.-H.L., S.M.S., D.F.J., J.J.B., B.Y.C.); the Duke Cancer Institute, Duke University, Durham, NC (S.S.D., J.Z.); the Division of Hematology-Oncology, Department of Medicine, Hofstra North Shore-LIJ School of Medicine, New Hyde Park, NY (J.C. Barrientos); and Janssen Research and Development, Beerse, Belgium (M.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1400029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144824PMC
June 2014

Graft-versus-host disease: why have we not made more progress?

Curr Opin Hematol 2014 Mar;21(2):141-7

Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0000000000000026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131840PMC
March 2014

Novel therapies and their integration into allogeneic stem cell transplant for chronic lymphocytic leukemia.

Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S132-8

Department of Internal Medicine, Division of Hematology and Oncology, Comprehensive Cancer Center at The Ohio State University, Columbus, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.11.018DOI Listing
January 2012

Choosing first-line therapy for chronic lymphocytic leukemia.

Expert Rev Anticancer Ther 2011 Sep;11(9):1379-90

Division of Hematology, Ohio State University, A352 Starling-Loving Hall, 320 West 10th Avenue, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.11.132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4341916PMC
September 2011

The clinical application of monoclonal antibodies in chronic lymphocytic leukemia.

Blood 2010 Nov 7;116(19):3705-14. Epub 2010 Jul 7.

Division of Hematology-Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-04-00
Publisher Site
http://dx.doi.org/10.1182/blood-2010-04-001230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2981531PMC
November 2010

Rituximab in chronic lymphocytic leukemia.

Semin Hematol 2010 Apr;47(2):156-69

Division of Hematology-Oncology, Department of Medicine, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2010.01.005DOI Listing
April 2010

Lymphoma in adolescents and young adults.

Semin Oncol 2009 Oct;36(5):381-418

Department of Hematology, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2009.07.009DOI Listing
October 2009

Lovenox hurts.

Ann Intern Med 2009 Oct;151(8):585-6

The Ohio State University, Columbus, OH 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00015DOI Listing
October 2009